Clinical Trials Logo

Clinical Trial Summary

Arthroplasty increases the risk of postoperative urinary retention. Treatment of postoperative urinary retention is indwelling or intermittent catheterization. The need for catheterization is most commonly determined with an ultrasound scanner. Catheterization increases the risk of urinary tract infection, which may further lead to haematogenic infection of the artificial joint. There is no evidence of an optimal way to monitor the onset of spontaneous urination. The aim of the study is to determine whether monitoring the onset of spontaneous urination after fast track knee arthroplasty is safe based on symptoms alone without ultrasound monitoring.


Clinical Trial Description

Adult patients undergoing knee arthroplasty will be recruited to this study. Participants will be randomized to the ultrasound monitoring group or the symptoms alone group. In the symptoms alone group, urination is monitored by asking at regular intervals about the onset of spontaneous urination and the patient is catheterized only on a symptomatic basis or if spontaneous voiding has not started 10 hours after the spinal anesthesia. Symptoms that indicate catheterization are lower abdominal pain or need to void. In the ultrasound group, urinary retention is monitored according to current practice with an ultrasound scanner and the patient is catheterized if residual urine exceeds 800 ml or if the patient is symptomatic. The primary outcome variable is the change in IPSS score from the baseline to 3 months after the procedure. The baseline score is evaluated preoperatively. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04707001
Study type Interventional
Source Central Finland Hospital District
Contact Juha Paloneva, professor
Phone 014 269 1680
Email juha.paloneva@ksshp.fi
Status Recruiting
Phase N/A
Start date May 1, 2021
Completion date July 2026

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05181566 - Metal Ion Levels in Total Hip Arthroplasty (THA) With Modular Dual Mobility Cup Compared to Conventional THA N/A
Completed NCT04490304 - The Analysis of Posterior Soft Tissue Repair Durability N/A
Recruiting NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT04565093 - Efficacy of iPACK After Unilateral TKA N/A
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Recruiting NCT03306810 - Recognition and Treatment of Dysglycemia. AGS - Acute Glucose Service N/A
Completed NCT04289025 - Modelling and AI Using Sensor Data to Personalise REHABilitation Following Joint Replacement N/A
Not yet recruiting NCT05014932 - Evaluation of Noise Induced by Ceramic-ceramic Friction Torques of Total Hip Prostheses With Customized Femoral Stem
Active, not recruiting NCT04437888 - Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty Early Phase 1
Completed NCT05420194 - Assessment of Postural Stability in Patients With Total Knee Arthroplasty
Completed NCT03269760 - Multimodal Sleep Pathway for Shoulder Arthroplasty Phase 1
Completed NCT03289247 - Tissue Adhaesive in Wound Closure Following Primary Total Knee Arthroplasty N/A
Completed NCT04433962 - Investigation of the Effects of Balance Training on Balance and Functional Status Patients With Total Hip Arthroplasty N/A
Recruiting NCT06025448 - Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability? N/A
Recruiting NCT05459259 - Physiotherapy for Arthrofibrosis Following Knee Replacement.
Not yet recruiting NCT05736666 - Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement N/A
Active, not recruiting NCT03692364 - Evaluation of Metal-on-conventional-polyethylene vs Ceramic-on-ceramic Articulating Surfaces in Total Hip Arthroplasty N/A
Completed NCT05013879 - Kinesiotape for Edema After Bilateral Total Knee Arthroplasty N/A
Completed NCT04120324 - Incidence of 30 Day Return to Hospital Following Same Day Discharge Total Hip Arthroplasty
Not yet recruiting NCT05509946 - Preemptive Analgesia Combination of Celecoxib and Pregabalin in THA Phase 2/Phase 3